Cryo-Cell International Other Current Assets

As of the most recent data (August 2026), CCEL shows a other current assets of $8.4M. That compares with $7.8M in the prior-year period — up 7.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CCEL's other current assets is now $8.4M (was $7.8M) — a 7.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Cryo-Cell International is outperforming or lagging.

Tracking CCEL's other current assets over time shows whether Cryo-Cell International is scaling, shrinking, or reshaping that part of the business. The current reading is $8.4M That compares with $7.8M in the prior-year period — up 7.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has Cryo-Cell International's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $8.4M) with ownership activity and broader fundamentals.

Cryo-Cell International's other current assets is $8.4M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.